Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors

2005 ◽  
Vol 55 (5) ◽  
pp. 497-501 ◽  
Author(s):  
Maria Luisa Veronese ◽  
Keith Flaherty ◽  
Amy Kramer ◽  
Barbara A. Konkle ◽  
Mark Morgan ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
The Novel

Dose escalation stage of a first-in-class phase I study of the novel oral ERK 1/2 kinase inhibitor BVD-523 (ulixertinib) in patients with advanced solid tumors.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 2506-2506 ◽  
Author(s):  
Jeffrey R. Infante ◽  
Filip Janku ◽  
Anthony W. Tolcher ◽  
Manish R. Patel ◽  
Ryan J. Sullivan ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Dose Escalation ◽  
Phase I Study ◽  
Kinase Inhibitor ◽  
Advanced Solid Tumors ◽  
The Novel

A phase I study of the novel, third generation epothilone ZK-EPO in patients with advanced solid tumors

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 2051-2051 ◽  
Author(s):  
P. Schmid ◽  
P. Kiewe ◽  
D. Kuehnhardt ◽  
A. Korfel ◽  
S. Lindemann ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Third Generation ◽  
Advanced Solid Tumors ◽  
The Novel

A phase I study of the novel DNA topoisomerase-1 inhibitor, TLC388, administered intravenously to patients with advanced solid tumors.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e13618-e13618 ◽  
Author(s):  
S. A. Ghamande ◽  
C. Lin ◽  
D. C. Cho ◽  
T. A. Coleman ◽  
I. Chaudhary ◽  
...  
Keyword(s):  
Phase I ◽  
Solid Tumors ◽  
Phase I Study ◽  
Advanced Solid Tumors ◽  
The Novel ◽  
Dna Topoisomerase ◽  
Topoisomerase 1
Sign in / Sign up

Export Citation Format

Share Document